ATMI

Active

Updated: Apr 2, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Mar 28, 2012	Promethera Biosciences	$31.4M Debt / Series B	—	Boehringer Ingelheim, Financière Spin-off Luxembourgeoise, Life Sciences Research Partners, Mitsui & Co. Global Investment, Nivelinvest, Sambrinvest, Shire, Sopartec, SRIW, Vesalius Biocapital, VIVES Louvain Technology Fund, Walloon Region

Total Raised

N/A

Valuation

N/A